| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3991611 | Journal of Thoracic Oncology | 2010 | 6 Pages |
Abstract
The prognosis of patients treated with two HDRA-positive drugs was significantly better than that of those treated with one HDRA-positive drug or HDRA-negative drugs. Adjuvant chemotherapy based on the in vitro HDRA may be useful to improve survival in patients who have undergone surgery.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Masayuki MD, Hiroshi MD, Haruhiro MD, Eriko MD, Hiroshi MD, Naoko MD,